X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare SUVEN LIFE with IPCA Labs - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SUVEN LIFE vs IPCA LABS - Comparison Results

IPCA LABS 
   Change

Ipca Laboratories is an integrated pharmaceutical company with presence in intermediates, APIs and formulations. The company has a strong focus on exports, catering to the US, Europe and the semi-regulated markets of the CIS, Africa and Asia. The com... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SUVEN LIFE IPCA LABS SUVEN LIFE/
IPCA LABS
 
P/E (TTM) x 15.9 34.9 45.5% View Chart
P/BV x 3.8 3.3 113.9% View Chart
Dividend Yield % 0.5 0.2 299.1%  

Financials

 SUVEN LIFE   IPCA LABS
EQUITY SHARE DATA
    SUVEN LIFE
Mar-17
IPCA LABS
Mar-17
SUVEN LIFE/
IPCA LABS
5-Yr Chart
Click to enlarge
High Rs229643 35.5%   
Low Rs151503 30.1%   
Sales per share (Unadj.) Rs42.7254.4 16.8%  
Earnings per share (Unadj.) Rs6.916.1 42.6%  
Cash flow per share (Unadj.) Rs8.529.8 28.7%  
Dividends per share (Unadj.) Rs1.001.00 100.0%  
Dividend yield (eoy) %0.50.2 301.8%  
Book value per share (Unadj.) Rs52.4194.6 26.9%  
Shares outstanding (eoy) m127.28126.20 100.9%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.42.3 197.4%   
Avg P/E ratio x27.735.7 77.7%  
P/CF ratio (eoy) x22.219.2 115.6%  
Price / Book Value ratio x3.62.9 123.0%  
Dividend payout %14.66.2 234.6%   
Avg Mkt Cap Rs m24,15872,300 33.4%   
No. of employees `0001.013.3 7.6%   
Total wages/salary Rs m5226,960 7.5%   
Avg. sales/employee Rs Th5,349.72,413.5 221.7%   
Avg. wages/employee Rs Th513.5523.2 98.1%   
Avg. net profit/employee Rs Th858.1152.4 562.9%   
INCOME DATA
Net Sales Rs m5,43532,106 16.9%  
Other income Rs m211226 93.5%   
Total revenues Rs m5,64632,332 17.5%   
Gross profit Rs m1,2914,448 29.0%  
Depreciation Rs m2141,730 12.4%   
Interest Rs m57241 23.6%   
Profit before tax Rs m1,2312,703 45.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m359675 53.1%   
Profit after tax Rs m8722,028 43.0%  
Gross profit margin %23.713.9 171.4%  
Effective tax rate %29.225.0 116.7%   
Net profit margin %16.06.3 254.0%  
BALANCE SHEET DATA
Current assets Rs m4,91717,340 28.4%   
Current liabilities Rs m1,1869,559 12.4%   
Net working cap to sales %68.624.2 283.3%  
Current ratio x4.11.8 228.6%  
Inventory Days Days62100 61.9%  
Debtors Days Days3157 54.1%  
Net fixed assets Rs m3,15420,779 15.2%   
Share capital Rs m127252 50.4%   
"Free" reserves Rs m6,54324,499 26.7%   
Net worth Rs m6,67024,553 27.2%   
Long term debt Rs m2593,517 7.4%   
Total assets Rs m8,15739,595 20.6%  
Interest coverage x22.712.2 185.4%   
Debt to equity ratio x00.1 27.1%  
Sales to assets ratio x0.70.8 82.2%   
Return on assets %11.45.7 198.7%  
Return on equity %13.18.3 158.3%  
Return on capital %18.610.5 177.2%  
Exports to sales %048.6 0.0%   
Imports to sales %014.2 0.0%   
Exports (fob) Rs mNA15,617 0.0%   
Imports (cif) Rs mNA4,571 0.0%   
Fx inflow Rs m4,99615,617 32.0%   
Fx outflow Rs m9595,828 16.5%   
Net fx Rs m4,0379,790 41.2%   
CASH FLOW
From Operations Rs m1,0882,764 39.4%  
From Investments Rs m-3,107-1,432 217.0%  
From Financial Activity Rs m-300-1,591 18.9%  
Net Cashflow Rs m-2,319-259 895.9%  

Share Holding

Indian Promoters % 63.4 45.9 138.1%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 11.4 -  
FIIs % 0.0 25.3 -  
ADR/GDR % 0.0 0.0 -  
Free float % 36.5 17.4 209.8%  
Shareholders   37,287 36,892 101.1%  
Pledged promoter(s) holding % 0.0 2.1 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SUVEN LIFE With:   ABBOTT INDIA  NATCO PHARMA  BIOCON LTD  PFIZER  ALKEM LABORATORIES  

Compare SUVEN LIFE With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Trades on a Volatile Note; Idea Cellular Plunges 6%(12:30 pm)

After opening the day flat share markets in India are trading on a dull note and are presently trading marginally below the dotted line.

Related Views on News

IPCA LABS Announces Quarterly Results (4QFY18); Net Profit Up 15.6%

May 30, 2018 | Updated on May 30, 2018

For the quarter ended March 2018, IPCA LABS has posted a net profit of Rs 513 m (up 15.6% YoY). Sales on the other hand came in at Rs 8 bn (up 17.6% YoY). Read on for a complete analysis of IPCA LABS's quarterly results.

Suven Lifesciences: Profits Decline due to Higher tax outgo in the quarter (Quarterly Results Update - Detailed)

Sep 22, 2017

Muted growth in CRAMS segment continues to impact topline.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

More Views on News

Most Popular

Alert: Pharma Stocks Are About to Shoot Up - And a Superb Stock for Trading(Profit Hunter)

Jun 13, 2018

The ailing pharma stocks are bouncing back to health. Read this to find out the best way to profit from them.

Will You Dump Your Client if You're Busy? Inox Wind's Auditor Just Did...(The 5 Minute Wrapup)

Jun 14, 2018

After Inox Wind, you may see more auditors resigning And the reasons can be as funny as they can get.

GST Will Not Solve Problem of High Prices of Petrol and Diesel(Vivek Kaul's Diary)

Jun 13, 2018

Though it will bring transparency in their pricing and that in itself will be a welcome move.

Should You Invest In Mirae Asset Healthcare Fund?(Outside View)

Jun 15, 2018

Mirae Asset Mutual Fund launches NFO - Mirae Asset Helathcare Fund.

This Behaviour is Injurious to Wealth Building(Sector Info)

Jun 13, 2018

Blindly following the herd can be the biggest wealth destroyer.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

SUVEN LIFE SHARE PRICE


Jun 25, 2018 03:19 PM

TRACK SUVEN LIFE

  • Track your investment in SUVEN LIFE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

SUVEN LIFE 8-QTR ANALYSIS

COMPARE SUVEN LIFE WITH

MARKET STATS